ARDX CIK: 1437402

Ardelyx Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−153
FY22:
−70.0
FY23:
−89.7
FY24:
−44.8
FY25:
−42.5
Change from FY21 to FY25
millions USD
FY21:
50.9
FY22:
18.4
FY23:
−131
FY24:
−18.3
FY25:
−8.96
Change from FY21 to FY25
millions USD
FY21:
83.0
FY22:
75.3
FY23:
146
FY24:
107
FY25:
54.5
millions USD
FY21:
−18.6
FY22:
23.7
FY23:
−74.7
FY24:
43.5
FY25:
3.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
−154
FY22:
−70.1
FY23:
−90.1
FY24:
−45.8
FY25:
−44.0

All amounts in millions USD Data source:SEC EDGAR